{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:42:19Z","timestamp":1791531739630,"version":"4.3.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2587,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1002\/hep.22391","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T03:17:29Z","timestamp":1209871049000},"page":"487-496","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":35,"title":["Activation of nuclear factor E2\u2010related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development\u2020"],"prefix":"10.1097","volume":"48","author":[{"given":"Silke","family":"Marhenke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Laml\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Elisa","family":"Buitrago\u2010Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel Fern\u00e1ndez","family":"Ca\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Geffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Finegold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Grompe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20241201","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/s-2001-19035","article-title":"The pathophysiology and treatment of hereditary tyrosinemia type 1","volume":"21","author":"Grompe","year":"2001","journal-title":"Semin Liver Dis"},{"key":"R2-16-20241201","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/bbrc.1997.6220","article-title":"The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion","volume":"232","author":"Jorquera","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"R3-16-20241201","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0891-5849(03)00273-9","article-title":"Pharmacological rescue of the 14CoS\/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress","volume":"35","author":"Dieter","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"R4-16-20241201","first-page":"317","article-title":"Visceral pathology of hereditary tyrosinemia type I","volume":"47","author":"Russo","year":"1990","journal-title":"Am J Hum Genet"},{"key":"R5-16-20241201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-008-0793-1","article-title":"NTBC treatment in tyrosinaemia type I: long\u2010term outcome in French patients","volume":"31","author":"Masurel\u2010Paulet","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"R6-16-20241201","first-page":"90","article-title":"Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2\u2010(2 nitro\u20104\u20103 trifluoro\u2010 methylbenzoyl)\u20101, 3\u2010cyclohexanedione treatment","volume":"40","author":"van Spronsen","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R7-16-20241201","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice","volume":"7","author":"Grompe","year":"1993","journal-title":"Genes Dev"},{"key":"R8-16-20241201","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"Grompe","year":"1995","journal-title":"Nat Genet"},{"key":"R9-16-20241201","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/mgme.2001.3266","article-title":"Long\u2010term therapy with NTBC and tyrosine\u2010restricted diet in a murine model of hereditary tyrosinemia type I","volume":"75","author":"Al\u2010Dhalimy","year":"2002","journal-title":"Mol Genet Metab"},{"key":"R10-16-20241201","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/hep.20077","article-title":"Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death","volume":"39","author":"Vogel","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R11-16-20241201","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jhep.2007.09.014","article-title":"Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah(\u2212\/\u2212) knockout mice model","volume":"48","author":"Orejuela","year":"2008","journal-title":"J Hepatol"},{"key":"R12-16-20241201","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF\u2010E2\u2010related factor 2 (Nrf2), a NF\u2010E2\u2010like basic leucine zipper transcriptional activator that binds to the tandem NF\u2010E2\/AP1 repeat of the beta\u2010globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-16-20241201","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1073\/pnas.081082098","article-title":"An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen","volume":"98","author":"Chan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-16-20241201","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.bcp.2006.02.017","article-title":"Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1","volume":"71","author":"Langlois","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"R15-16-20241201","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-16-20241201","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1074\/jbc.M506804200","article-title":"Involvement of endoplasmic reticulum stress in hereditary tyrosinemia type I","volume":"281","author":"Bergeron","year":"2006","journal-title":"J Biol Chem"},{"key":"R18-16-20241201","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1158\/0008-5472.CAN-04-4539","article-title":"The synthetic triterpenoids, CDDO and CDDO\u2010imidazolide, are potent inducers of heme oxygenase\u20101 and Nrf2\/ARE signaling","volume":"65","author":"Liby","year":"2005","journal-title":"Cancer Res"},{"key":"R19-16-20241201","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrc2129","article-title":"Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer","volume":"7","author":"Liby","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R20-16-20241201","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0046-8177(89)90179-2","article-title":"Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver","volume":"20","author":"Dehner","year":"1989","journal-title":"Hum Pathol"},{"key":"R21-16-20241201","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.gastro.2006.03.045","article-title":"c\u2010Jun N\u2010terminal kinase plays a major role in murine acetaminophen hepatotoxicity","volume":"131","author":"Gunawan","year":"2006","journal-title":"Gastroenterology"},{"key":"R22-16-20241201","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1053\/j.gastro.2004.08.053","article-title":"Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity","volume":"127","author":"Liu","year":"2004","journal-title":"Gastroenterology"},{"key":"R23-16-20241201","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI25790","article-title":"Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis","volume":"116","author":"Thimmulappa","year":"2006","journal-title":"J Clin Invest"},{"key":"R24-16-20241201","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1096\/fasebj.13.15.2284","article-title":"Cyclin B\u2010dependent kinase and caspase\u20101 activation precedes mitochondrial dysfunction in fumarylacetoacetate\u2010induced apoptosis","volume":"13","author":"Jorquera","year":"1999","journal-title":"FASEB J"},{"key":"R25-16-20241201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","article-title":"Glutathione transferases","volume":"45","author":"Hayes","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R26-16-20241201","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/hmg\/10.17.1741","article-title":"Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability","volume":"10","author":"Jorquera","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R27-16-20241201","first-page":"1111","article-title":"DNA ploidy abnormalities in the liver of children with hereditary tyrosinemia type I. Correlation with histopathologic features","volume":"140","author":"Zerbini","year":"1992","journal-title":"Am J Pathol"},{"key":"R28-16-20241201","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00042-4","article-title":"Liver tumor development. c\u2010Jun antagonizes the proapoptotic activity of p53","volume":"112","author":"Eferl","year":"2003","journal-title":"Cell"},{"key":"R29-16-20241201","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nm1377","article-title":"A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells","volume":"12","author":"Lee","year":"2006","journal-title":"Nat Med"},{"key":"R30-16-20241201","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.21552","article-title":"Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis","volume":"45","author":"Plentz","year":"2007","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22391","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200808000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:17:26Z","timestamp":1733059046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200808000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22391","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}